华纳药厂
(688799)
| 流通市值：59.58亿 | | | 总市值：59.58亿 |
| 流通股本：1.34亿 | | | 总股本：1.34亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 966,573,106.12 | 660,691,577.24 | 324,546,325.12 | 1,504,231,254.46 |
| 营业总成本 | 857,286,423.44 | 593,388,043.18 | 292,515,876.27 | 1,359,745,544.14 |
| 其他经营收益 | | | | |
| 营业利润 | 115,646,798.81 | 74,781,560.6 | 33,189,779.01 | 240,484,942.22 |
| 利润总额 | 112,368,807 | 74,579,933.77 | 33,188,649.26 | 240,895,081 |
| 净利润 | 82,793,748.32 | 64,599,830 | 26,876,979.68 | 228,098,328.6 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 82,793,748.32 | 64,599,830 | 26,876,979.68 | 228,098,328.6 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,064,017,867.72 | 1,129,644,491.22 | 1,106,687,552.08 | 1,176,225,379.93 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,630,081,835.09 | 2,309,170,841.63 | 2,133,487,631.94 | 1,877,418,088.93 |
| 资产总计 | 3,694,099,702.81 | 3,438,815,332.85 | 3,240,175,184.02 | 3,053,643,468.86 |
| 流动负债: | | | | |
| 流动负债合计 | 586,462,869.8 | 439,303,793.76 | 391,168,967.12 | 410,702,784.87 |
| 非流动负债: | | | | |
| 非流动负债合计 | 959,457,858.06 | 875,795,368.08 | 773,175,454.01 | 600,255,786.38 |
| 负债合计 | 1,545,920,727.86 | 1,315,099,161.84 | 1,164,344,421.13 | 1,010,958,571.25 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,148,178,974.95 | 2,123,716,171.01 | 2,075,830,762.89 | 2,042,684,897.61 |
| 股东权益合计 | 2,148,178,974.95 | 2,123,716,171.01 | 2,075,830,762.89 | 2,042,684,897.61 |
| 负债和股东权益合计 | 3,694,099,702.81 | 3,438,815,332.85 | 3,240,175,184.02 | 3,053,643,468.86 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 891,413,655.24 | 606,243,909.74 | 319,304,553.27 | 1,397,762,072.38 |
| 经营活动现金流出小计 | 613,853,931.25 | 439,508,923.89 | 246,251,535.65 | 1,097,561,561.72 |
| 经营活动产生的现金流量净额 | 277,559,723.99 | 166,734,985.85 | 73,053,017.62 | 300,200,510.66 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 948,180,219.5 | 577,769,140.21 | 100,183,567.85 | 651,180,864.88 |
| 投资活动现金流出小计 | 1,567,700,026.5 | 942,403,768.98 | 358,689,970.43 | 1,260,355,569.51 |
| 投资活动产生的现金流量净额 | -619,519,807 | -364,634,628.77 | -258,506,402.58 | -609,174,704.63 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 849,624,044.79 | 764,089,884.71 | 174,398,227 | 398,970,229.4 |
| 筹资活动现金流出小计 | 498,336,230.86 | 480,091,774.86 | 3,817,650.12 | 62,964,210.34 |
| 筹资活动产生的现金流量净额 | 351,287,813.93 | 283,998,109.85 | 170,580,576.88 | 336,006,019.06 |
| 汇率变动对现金及现金等价物的影响 | -1,990,020.13 | -1,366,483.74 | -645,151.4 | -993,338.01 |
| 现金及现金等价物净增加额 | 7,337,710.79 | 84,731,983.19 | -15,517,959.48 | 26,038,487.08 |
| 期末现金及现金等价物余额 | 208,816,138.45 | 286,210,410.85 | 185,960,468.18 | 201,478,427.66 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 84,731,983.19 | - | 26,038,487.08 |